Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | HTR3A | P46098 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12711323 | 0.81 | CYP2A6 (0.37) | CYP2A6 | |
| SCHEMBL12430648 | 0.78 | CYP2A6 (0.57) | CYP2A6CHRNA7HTR3AESR1ESR2 | |
| SCHEMBL12711299 | 0.77 | ESR1 (0.38) | ESR1ESR2MAPT | |
| SCHEMBL12711283 | 0.74 | NPC1 (0.32) | MAPT | |
| SCHEMBL12711388 | 0.71 | HSD17B1 (0.33) | — | |
| SCHEMBL12711322 | 0.70 | CYP2A6 (0.40) | CYP2A6CHRNA7HTR3AESR1ESR2 | |
| SCHEMBL12711313 | 0.70 | CYP2A6 (0.40) | CYP2A6ESR1ESR2MAPTRAB9A | |
| SCHEMBL12711615 | 0.69 | CYP2A6 (0.39) | CYP2A6ESR1ESR2 | |
| SCHEMBL12711272 | 0.67 | — | — | |
| SCHEMBL12269095 | 0.66 | CYP2A6 (0.45) | CYP2A6ESR1ESR2MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | CYP2A6 1465/4885CHRNA7 3007/4885HTR3A 545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.